Abstract
Constipation is a common community health problem. There are many factors that are widely thought to be associated with constipation but real-world evidence of these associations is difficult to locate. These potential risk factors may be categorised as demographic, lifestyle and health-related factors. This review presents the available evidence for each factor by an assessment of quantitative data from cross-sectional studies of community-dwelling adults published over the last 30 years. It appears that there is evidence of an association between constipation and female gender, residential location, physical activity and some health-related factors such as self-rated health, some surgery, certain medical conditions and certain medications. The available evidence for most other factors is either conflicting or insufficient. Therefore, further research is necessary to determine if each factor is truly associated with constipation and whether it can be regarded as a potential risk factor. It is recommended that studies investigating a broad range of factors are conducted in populations in community settings. Multivariate analyses should be performed to account for all possible confounding factors. In this way, valuable evidence can be accumulated for a better understanding of potential risk factors for constipation in the community.
Keywords: Adults, Constipation, Epidemiology, Factors, Community
Core Tip: Despite widespread beliefs that there are a number of potential risk factors for constipation in the community, this review highlights the paucity of real-world evidence for most factors. It is unclear whether most factors are associated with constipation because, apart from female gender, physical activity, residential location and some health-related factors, there is insufficient evidence or conflicting data available. Further research is required in community-dwelling adult populations to understand the importance of each potential risk factor in constipation. A broad range of factors should be investigated in same population samples using multivariate analysis to determine which factors are truly associated with constipation in the community.
INTRODUCTION
One of the most common health problems faced by the community is constipation[1]. In general, constipation can be defined as a lack of satisfactory defecation[1] which incorporates various symptoms and may be either chronic or sporadic. Chronic constipation is usually defined by a set of clinical symptoms known as the Rome criteria[2]; the Rome criteria have been revised several times following their introduction as Rome I criteria in 1994. Any constipation may be defined as constipation which includes both chronic and sporadic constipation[3]; this condition is generally self-reported in epidemiological studies.
A number of factors are widely considered to be associated with constipation however real-world evidence of these associations appears to be sparse[4,5]. It is widely accepted that prime risk factors for constipation in the community include low exercise levels, low fibre intake and inadequate fluid intake[6]. However, these risk factors have been challenged in the past due to a paucity of clinical evidence[4,5]. In addition to these factors, there are other determinants of health which are reported in the literature to be associated with constipation. These include lifestyle and demographic factors[7]. Furthermore, medications and medical conditions are well established as two major secondary causes of constipation[8,9].
Since there appears to be questionable real-world evidence for these various risk factors despite their wide acceptance in the community, this literature review seeks to assess each potential risk factor by reviewing evidence from population-based studies of community-dwelling adult populations. The specific aims of this review were to identify demographic, lifestyle and health-related factors reported to be associated with constipation and evaluate the evidence for each factor.
SEARCH STRATEGY
A search of relevant published literature was performed using the Ovid interface to MEDLINE and Embase electronic databases. In addition, some articles were located in PubMed. The “ancestry approach”[10] was also used to locate pertinent studies by searching references of selected articles.
The search was filtered to include only English language articles and population-based studies. Index search terms in various combinations were applied using the three main Boolean operators – AND, OR and NOT, and included: “constipation”, “adults”, “gastrointestinal disorders”, “prevalence”, “epidemiology”, “factors” and “risk factors”. Articles meeting the inclusion criteria were classified into chronic constipation and any constipation according to the definition of constipation used in the study. Because of the large number of articles published on these topics, the search was limited to articles which were published between 1989 and 2019.
Retrieved articles that were eligible for inclusion included peer-reviewed research articles, as well as systematic reviews, describing epidemiological studies in community settings. Articles reporting constipation relating to irritable bowel syndrome, opioid-induced constipation in cancer, faecal incontinence, bowel cleansing, constipation in infants and children, constipation in palliative care patients, constipation in hospital in-patients and constipation in residential care facilities were deemed inappropriate for this review and were excluded from the final literature review sample. Articles describing specific subpopulations such as those relating to university students, older adult populations (50 years of age and older), female populations and male populations were excluded. Since the focus for this review was population-based studies, surveys where the sample size was fewer than 100 participants were also excluded.
Articles meeting the preliminary inclusion criteria were further screened. Articles were excluded when found to report results from employee groups[11-14], patient groups[15-19], and medical database records[20,21] as these were deemed not to be community settings. Self-reported constipation incorporates many and varied symptoms[22,23] and chronic constipation, as defined by Rome criteria, incorporates all possible symptoms of chronic constipation[2]; therefore, articles reporting only one symptom such as stool consistency or bowel motion frequency rather than constipation per se were not included in the final sample[24-31]. Also excluded were articles where the adult population sample was found to include participants below the age of 15 years[32-35].
In some articles there were sufficient data available to enable calculation of results for potential risk factors even though these results were not published; these included calculations of prevalence percentages and gender ratios. Any calculated data are clearly marked as such in the tables. However, in some epidemiological studies of general populations, the results reporting potential risk factors have been reported by gender only and it was not possible to amalgamate the data for inclusion of several factors in this review.
RESULTS
A final sample comprising 53 articles was selected for inclusion in this literature review. Of these, 9 were systematic reviews and 44 were quantitative epidemiological studies of community-based general adult populations. Three systematic reviews were international[7,36,37], two related to specific regions – North America[38] and Europe plus Oceania[39], and two related to specific countries – Iran[40] and China[41]. Another two reviews related to specific factors – co-morbidities and haemorrho-ids[42,43]. The epidemiological studies were all cross-sectional surveys of adults residing in the community.
Factors potentially associated with constipation which emanated from our review included demographic factors (age, gender, income, education, work status and geography), lifestyle factors and behaviours (physical activity, smoking, and fibre, fluid, alcohol and coffee intakes) and numerous health-related factors (including medical conditions and medications). Each of these factors are discussed in turn.
DEMOGRAPHIC AND SOCIOECONOMIC FACTORS
The following section describes demographic and socioeconomic factors potentially associated with constipation in adults in community settings.
Age
For both chronic constipation and any constipation, it seems that there is not a clear association with age since conflicting results have been reported (Table 1)[44-63]. There may be a higher prevalence of constipation in older age groups as reported in some literature reviews and epidemiological studies. However, other studies reported either no such association or a higher prevalence of constipation in younger age groups.
Table 1.
Ref. | Location | Sample size | Definition of constipation | Age range (yr) | Prevalence (%) | Odds ratio (95%CI) | P value |
Harari et al[62], 1989 | United States | 42375 | Self-report (12 mo) | < 40; 40-49; 50-59; 60-69; 70-79; > 80 | 2.6; 2.6; 2.9; 4.1; 5.5; 10.0 | 1.00; 1.00 (0.84, 1.18); 1.11 (0.92, 1.33); 1.60 (1.36, 1.86); 2.11 (1.80, 2.46); 3.80 (3.22, 4.49) | NR |
Drossman et al[44], 1993 | United States | 5430 | Rome I | 15-34; 35-49; > 45 | 3.8; 3.6; 3.5 | NR | NR |
Talley et al[49], 1993 | United States | 690 | Rome I | 30-39; 60-64 | 25; 15 | NR | < 0.05 |
Pare et al[45], 2001 | Canada | 1149 | Self-report (3 mo) | 18-34; 35-49; 50-64; > 65 | 26.4; 28.4; 26.3; 27.4 | NR | NR |
Pare et al[45], 2001 | Canada | 1149 | Rome I | 18-34; 35-49; 50-64; > 65 | 20.3; 14.5; 15.1; 15.4 | NR | NR |
Pare et al[45], 2001 | Canada | 1149 | Rome II | 18-34; 35-49; 50-64; > 65 | 16.1; 12.9; 14.8; 16.7 | NR | NR |
Choung et al[63], 2006 | United States | 3022 | Self-report (12 mo) | < 50; > 50 | 1.321; 7.871 | NR | NR |
Wald et al[61], 2008 | United States | 2000 | Self-report (12 mo) | < 29; 30-44; 45-59; > 60 | 13.41; 19.11 17.51; 19.91 | NR | NR |
Chang et al[46], 2007 | United States | 523 | Rome III | < 50; > 50 | 18.2; 17.3 | 1.0; 0.94 (0.60, 1.48) | NR |
Meinds et al[47], 2017 | Netherlands | 1259 | Rome III | 18-34; 35-46; 47-55; 56-64; 65-85 | 36.3; 26.6; 19.0; 19.2; 19.8 | NR | < 0.001 |
Garrigues et al[60], 2004 | Spain | 349 | Self-report (12 mo) | 18-30; 31-50; 51-65 | 29.2; 29.2; 30.7 | NR | NS |
Fosnes et al[54], 2011 | Norway | 4622 | Rome II | NR | NR | 1.01 (1.003, 1.02) | 0.005 |
Rey et al[55], 2014 | Spain | 1500 | Rome III | 18-40; 41-65; > 65 | 19; 19; 20 | NR | |
Ebling et al[50], 2014 | Croatia | 658 | Rome III | 20-34; 35-49; 50-69 | 16.2; 22.7; 26.2 | NR | 0.035; 0.182 |
Papatheodoridis et al[51], 2010 | Greece | 1000 | Rome III or self-report (12 mo) | 15-29; 30-44; 45-59; 60-64 | 12; 16; 18; 25 | 0.422 (0.226, 0.788); 0.721 (0.397, 1.310); 0.670 (0.362, 1.241); 1.0 | 0.007; 0.283; 0.203; 0.010 |
Wald et al[61], 2008 | United Kingdom | 2000 | Self-report (12 mo) | < 29; 30-44; 45-59; > 60 | 5.91; 7.71; 8.11; 9.11 | NR | NR |
Wald et al[61], 2008 | France | 2000 | Self-report (12 mo) | < 29; 30-44; 45-59; > 60 | 12.21; 12.41; 9.41; 22.01 | NR | NR |
Wald et al[61], 2008 | Germany | 2000 | Self-report (12 mo) | < 29; 30-44; 45-59; > 60 | 1.51; 4.31; 5.51; 8.71 | NR | NR |
Wald et al[61], 2008 | Italy | 2000 | Self-report (12 mo) | < 29; 30-44; 45-59; > 60 | 5.81; 6.91; 8.91 10.61 | NR | NR |
Wald et al[59], 2010 | China | 2100 | Self-report (12 mo) | < 29; 30-44; 45-59 | 12.71; 16.01; 18.61 | NR | NR |
Wald et al[59], 2010 | Indonesia | 2000 | Self-report (12 mo) | < 29; 30-44; 45-59; > 60; | 11.61; 13.51; 15.31; 9.61 | NR | NR |
Wald et al[59], 2010 | South Korea | 2000 | Self-report (12 mo) | < 29; 30-44; 45-59; > 60; | 18.11; 15.61; 16.91; 14.11 | NR | NR |
Jun et al[58], 2006 | South Korea | 1029 | Self-report (3 mo) | 15-19; 20-29; 30-39; 40-49; 50-59; > 60 | 22; 22; 15; 15; 14; 12 | NR | 0.003 |
Cheng et al[57], 2003 | Hong Kong | 3282 | Rome II | < 30; 30-39; 40-49; 50-59; > 59 | 14.5; 13.6; 11.8; 13.7; 14.9 | NR | NR |
Lu et al[56], 2006 | Taiwan | 2018 | Rome II | 20-29; 30-39; 40-49; 50-59; 60-69; 70-79 | 12.2; 7.9; 7.4; 7.1; 10.4; 11.9 | NR | 0.04 |
Sorouri et al[53], 2010 | Iran | 18180 | Rome III | < 40; 40-60; > 60 | 1.4; 4.7; 4.9 | 1.01 (1, 1.01) | < 0.05 |
Moezi et al[52], 2018 | Iran | 9264 | Rome IV | 40-59; > 60 | 6.91; 11.91 | 1.55 (1.31, 1.83) | < 0.001 |
Wald et al[59], 2010 | Argentina | 2000 | Self-report (12 mo) | < 29; 30-44; 45-59; > 60 | 11.61; 12.31; 17.11; 17.31 | NR | NR |
Wald et al[59], 2010 | Colombia | 2000 | Self-report; (12 mo) | < 29; 30-44; 45-59; > 60 | 19.61; 25.61; 25.31; 25.51 | NR | NR |
Wald et al[59], 2010 | Brazil | 2000 | Self-report (12 mo) | < 29; 30-44; 45-59; > 60 | 13.91; 17.31; 19.41; 19.01 | NR | NR |
Howell et al[48], 2006 | Sydney | 1673 | Rome II | 25-34; 35-44; 45-54; 55-64 | 37.8; 27.7; 27.4; 27.6 | NR | 0.03 |
Calculated from data published. NR: Not reported; NS: Not significant.
For chronic constipation, one systematic review[36] found no significant differences in prevalence between younger and older age groups whereas reviews of Chinese[41] and Iranian[40] studies indicated an increased prevalence with age. Six epidemiological studies indicated higher prevalence of chronic constipation in younger age groups[44-49], whilst higher prevalence in older age groups was only reported in four studies[50-53]. Furthermore, in establishing an association between chronic constipation and age groups, four other studies did not demonstrate any trends[54-57].
For any constipation (chronic and sporadic), one systematic review[7] found an increased prevalence of any constipation after the age of 60 years with the largest increase in prevalence experienced after 70 years. Trends of increasing prevalence with increasing age were observed in three reviews[37,40,41], but one review of North American studies[38] concluded that the relationship between age and any constipation could not be established. An increase in any constipation with increasing age has been reported in epidemiological studies from various countries[58-61]; however, the prevalence of any constipation decreased with increasing age in studies elsewhere[58,59] (Table 1). In other epidemiological studies, no clear association of age and any constipation was seen[45,59-61].
Female gender
The prevalence of constipation is consistently higher in females compared to males in all systematic reviews and almost all epidemiological studies included in this review (Table 2)[22,23,45-81]. Most studies reporting gender differences have used fe-male/male (F/M) ratios to express the result with only a few studies reporting odds ratios. Based on these data, it would appear that females are approximately twice as likely as males to report chronic constipation and more than twice as likely to report any constipation.
Table 2.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Prev. males (%) | Prev. females (%) | F/M ratio | Odds ratio (95%CI) | P value |
Everhart et al[67], 1989 | United States | 11204 | 25-74 | Self-report (NTP) | 3.6 | 11.4 | 3.171 | 3.8 (2.6, 5.6) | NR |
Talley et al[64], 1991 | United States | 835 | 30-64 | Rome I | 13.9 | 20.8 | 1.501 | 1.6 (1.1, 2.3) | NR |
Talley et al[49], 1993 | United States | 690 | 30-64 | Self-reportRome I | 2.7; 18.3 | 7.3; 20.1 | 2.701; 1.011 | NR | NR |
Drossman et al[44], 1993 | United States | 5430 | > 15 | Rome I | 2.4 | 4.8 | 2.001 | 1.99 (1.5, 2.7) | NR |
Stewart et al[68], 1999 | United States | 10018 | > 18 | Rome II | 12.0 | 16.0 | 1.331 | NR | NR |
Pare et al[45], 2001 | Canada | 1149 | > 18 | Self-report (3 mo) | 18.4 | 35.4 | 1.921 | NR | NR |
Pare et al[45], 2001 | Canada | 1149 | > 18 | Rome I | 12.0 | 21.0 | 1.751 | NR | NR |
Pare et al[45], 2001 | Canada | 1149 | > 18 | Rome II | 8.3 | 21.1 | 2.541 | NR | NR |
Choung et al[63], 2006 | United States | 2718 | 20-95 | Self-report (12 mo) | 2.761 | 6.441 | 2.331 | NR | NR |
Chang et al[46], 2007 | United States | 523 | 30-64 | Rome III | 17.8 | 17.8 | 1.00 | 1.0 (0.64, 1.57) | NR |
Wald et al[61], 2008 | United States | 2000 | > 15 | Self-report (12 mo) | 13.6 | 21.4 | 1.57 | NR | NR |
Choung et al[65], 2012 | United States | 2853 | > 20 | Rome II | 20.11 | 27.71 | 1.381 | 1.6 (1.3, 1.9) | < 0.01 |
Choung et al[69], 2016 | United States | 2327 | > 25 | Rome III (mod) | 5.1 | 8.7 | 1.711 | NR | NR |
Meinds et al[47], 2017 | Netherlands | 1259 | > 18 | Rome III | 18.8 | 29.3 | 1.561 | 1.8 (1.4, 2.3) | < 0.001 |
Van Kerkhoven et al[70], 2008 | Netherlands | 1616 | > 18 | Self-report (4 wk) | 7 | 18 | 2.571 | NR | < 0.01 |
Garrigues et al[60], 2004 | Spain | 349 | 18-65 | Self-report (12 mo) | 18.0 | 40.1 | 2.231 | 2.9 (1.68, 4.98) | 0.0001 |
Garrigues et al[60], 2004 | Spain | 349 | 18-65 | Rome II | 5.5 | 22.0 | 4.01 | 4.58 (1.98, 10.60) | 0.0004 |
Walter et al[22], 2002 | Sweden | 1610 | 31-76 | Self-report (NTP) | 8.3 | 19.8 | 2.391 | NR | < 0.0001 |
Haug et al[71], 2002 | Norway | 62651 | > 20 | Self-report (12 mo) | 1.5 | 5.7 | 3.81 | NR | < 0.05 |
Fosnes et al[54], 2011 | Norway | 4622 | 31-76 | Rome II | 6.71 | 19.31 | 2.881 | 3.24 (2.61, 4.02) | < 0.001 |
Gaburri et al[72], 1989 | Italy | 519 | NR | Self-report (3 yr) | 1.21 | 8.11 | 6.751 | NR | NR |
Heaton et al[73], 1993 | United Kingdom | 1892 | 26-69 | Self-report (NTP) | 14.7 | 31.1 | 2.121 | NR | < 0.001 |
Wald et al[61], 2008 | United Kingdom | 2000 | > 15 | Self-report (12 mo) | 4.2 | 10.9 | 2.60 | NR | NR |
Wald et al[61], 2008 | Germany | 2000 | > 15 | Self-report (12 mo) | 3.0 | 7.5 | 2.5 | NR | NR |
Wald et al[61], 2008 | Italy | 2000 | > 15 | Self-report (12 mo) | 4.9 | 10.8 | 2.2 | NR | NR |
Wald et al[61], 2008 | France | 2000 | > 15 | Self-report (12 mo) | 8.6 | 18.9 | 2.2 | NR | NR |
Rey et al[55], 2014 | Spain | 1500 | > 18 | Rome III | 10.6 | 27.6 | 2.7 | NR | NR |
Esteban y Peña et al[74], 2014 | Spain | 7341 | > 16 | Self-report (NTP) | 1.9 | 5.9 | 3.11 | NR | < 0.001 |
Enck et al[75], 2016 | Germany | 15002 | > 18 | Self-report (12 mo) | NR | NR | 2.3 | NR | NR |
Ebling et al[50], 2014 | Croatia | 658 | 20-70 | Rome III | 24.3 | 20.3 | 0.841 | NR | 0.2260.126 |
Papatheodoridis et al[51], 2010 | Greece | 1000 | 15-64 | Rome III or self-report (12 mo) | 11 | 21 | 1.911 | 2.10 (1.41, 3.12) | < 0.001 |
Wald et al[61], 2008 | Brazil | 2000 | > 15 | Self-report | 8.5 | 24.2 | 2.85 | NR | NR |
Wald et al[59], 2010 | Argentina | 2000 | > 15 | Self-report | 7.9 | 20.2 | 2.56 | NR | NR |
Wald et al[59], 2010 | Colombia | 2000 | > 15 | Self-report | 14.7 | 28.3 | 1.93 | NR | NR |
Schmidt et al[66], 2016 | Brazil | 2162 | > 18 | Rome III | 5.3 | 21.9 | 4.131 | 4.3 (3.1, 6.1) | NR |
Ho et al[76], 1998 | Singapore | 706 | 21-95 | Rome II | 2.8 | 5.6 | 2.01 | NR | NR |
Chen et al[77], 2000 | Singapore | 271 | > 16 | Rome II | 3.6 | 11.3 | 3.141 | NR | < 0.05 |
Cheng et al[57], 2003 | Hong Kong | 3282 | 18-80 | Rome II | 13.9 | 14.5 | 1.041 | NR | NR |
Lu et al[56], 2006 | Taiwan | 2018 | > 20 | Rome II | 7.01 | 10.61 | 1.511 | NR | < 0.001 |
Chang et al[78], 2012 | Taiwan | 4275 | > 19 | Rome III | 2.8 | 6.2 | 2.211 | NR | 0.001 |
Jun et al[58], 2006 | South Korea | 1029 | > 15 | Self-report (3 mo) | 10.4 | 22.8 | 2.191 | NR | < 0.001 |
Jeong et al[79], 2008 | South Korea | 1417 | 18-69 | Rome II | 0.5 | 5.0 | 10.01 | NR | < 0.05 |
Wald et al[61], 2008 | South Korea | 2000 | > 15 | Self-report (12 mo) | 10.7 | 22.7 | 2.12 | NR | NR |
Tamura et al[23], 2016 | Japan | 5155 | 20-79 | Self-report (NTP) | 19.1 | 37.5 | 1.961 | NR | < 0.001 |
Wald et al[59], 2010 | Indonesia | 2000 | > 15 | Self-report (12 mo) | 10.7 | 15.1 | 1.41 | NR | NR |
Wald et al[59], 2010 | China | 2100 | 15-60 | Self-report (12 mo) | 10.8 | 19.7 | 1.82 | NR | NR |
Sorouri et al[53], 2010 | Iran | 18180 | NR | Rome III | 1.2 | 3.7 | 3.081 | 1.83 (1.44, 2.32) | < 0.01 |
Moezi et al[52], 2018 | Iran | 9264 | 40-75 | Rome IV | 6.7 | 9.3 | 1.44 | NR | < 0.001 |
Talley et al[80], 1998 | Australia | 730 | > 18 | BSQ | 6.3 | 21.1 | 3.35 | NR | NR |
Howell et al[48], 2006 | Australia | 1673 | 25-64 | Rome II | 25.1 | 36.0 | 1.43 | NR | NR |
Koloski et al[81], 2015 | Australia | 3260 | > 18 | Rome III | 3.251 | 8.951 | 2.751 | NR | NR |
Calculated from published data. Prev.: Prevalence; F/M: Female/Male; Mod: Modified; NR: Not reported; NS: Not significant; NTP: No time period specified; BSQ: Bowel symptom questionnaire (similar to Rome criteria).
For chronic constipation, systematic reviews have reported mean F/M ratios of 1.4[41], 1.89[36] and 1.75[38,39]. Similar ratios are also seen in most epidemiological studies where F/M ratios have ranged from 1 to 10 in 24 studies conducted in various countries (Table 2). Only one study has shown a greater prevalence in males where the F/M ratio was 0.84[50]. Odds ratios for chronic constipation in females were reported as 2.22 in a global systematic review[36] and ranged from 1.0 to 4.8 in epidemiological studies[46,47,51,53,54,60,64-66].
For any constipation, systematic reviews have reported mean F/M ratios ranging from 2.1. to 2.65[7,38,39]. In 26 epidemiological studies, F/M ratios have ranged from 1.10 to 6.75 across 17 countries (Table 2). In 8 of these studies the difference between genders was reported to be statistically significant (P < 0.05). Odds ratios for any constipation in females ranged from 2.0 to 3.8 in systematic reviews[37,38] and epidemiological studies[59-61,67].
Income level
It is not clear from this literature review whether constipation and income are associated. The association of income level and constipation appears to vary by country but even within one country conflicting results have been reported (Table 3). In many countries, an inverse (negative) relationship has been found between constipation and income, with a higher prevalence of constipation with lower incomes.
Table 3.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Income/year or week | Prevalence (%) | Odds ratio (95%CI) | P value |
Stewart et al[68], 1999 | United States | 10018 | > 18 | Rome II | < $20000; $20-29900; $30-49900; > $50000 | NR | 1; 0.90; 1.10; 1.02 | NR |
Pare et al[45], 2001 | Canada | 1149 | > 18 | Self-report (3 mo) | < $20000; $20-39900; $40-59900; $60-79900; > $80000 | 33.8; 23.7; 24.3; 28.0; 21.8 | 1.55; 1.01; 1.11; 1.28; 1 | NR |
Pare et al[45], 2001 | Canada | 1149 | > 18 | Rome I | < $20000; $20-39900; $40-59900; $60-79900; > $80000 | 18.5; 16.3; 17.6; 13.1; 12.1 | 1.53; 1.35; 1.45; 1.08; 1 | NR |
Pare et al[45], 2001 | Canada | 1149 | > 18 | Rome II | < $20000; $20-39900; $40-59900; $60-79900; > $80000 | 15.3; 14.3; 13.9; 14.5; 8.3 | 1.84; 1.72; 1.67; 1.75; 1 | NR |
Wald et al[61], 2008 | United States | 2000 | > 15 | Self-report (12 mo) | Low; Middle; High | 20.9; 16.1; 16.8 | NR | NR |
Wald et al[61], 2008 | United Kingdom | 2000 | > 15 | Self-report (12 mo) | Low; Middle;High | 8.8; 7.27.1 | NR | NR |
Wald et al[61], 2008 | France | 2000 | > 15 | Self-report (12 mo) | Low; Middle; High | 14.9; 11.3; 15.8 | NR | NR |
Wald et al[61], 2008 | Germany | 2000 | > 15 | Self-report (12 mo) | Low; Middle; High | 7.2; 3.6; 5.3 | NR | NR |
Enck et al[75], 2016 | Germany | 15002 | > 18 | Self-report (12 mo) | < 1000; 1000-1500; 1500-2000; 2000-2500; 2500-3000; 3000-4000; > 4000 | 19.01; 18.81; 14.61; 13.61; 13.31; 11.31; 11.51 | NR | < 0.001 |
Wald et al[61], 2008 | Italy | 2000 | > 15 | Self-report (12 mo) | Low; Middle; High | 7.8; 7.0; 8.4 | NR | NR |
Wald et al[61], 2008 | Brazil | 2000 | > 15 | Self-report (12 mo) | Low; Middle; High | 17.9; 15.8; 14.2 | NR | NR |
Schmidt et al[66], 2016 | Brazil | 2162 | > 18 | Rome III | 2-15; 1.5-2; 1-1.5; 0.5-1; 0-0.5 | 11.1; 9.7; 13.8; 15.4; 21.8 | 1.0; 0.8 (0.5, 1.4); 1.3 (0.8, 2.1); 1.4 (0.9, 2.2); 1.9 (1.2, 3.0) | NR |
Wald et al[61], 2008 | South Korea | 2000 | > 15 | Self-report (12 mo) | Low; Middle; High | 17.1; 15.7; 17.1 | NR | NR |
Wald et al[59], 2010 | Colombia | 2000 | > 15 | Self-report (12 mo) | Low; Middle; High | 23.9; 20.3; 14.8 | NR | NR |
Wald et al[59], 2010 | China | 2100 | 15-60 | Self-report (12 mo) | Low; Middle; High | 16.2; 15.5; 13.2 | NR | NR |
Wald et al[59], 2010 | Indonesia | 2000 | > 15 | Self-report (12 mo) | Low; Middle; High | 13.1; 12.2; 14.0 | NR | NR |
Moezi et al[52], 2018 | Iran | 9264 | 40-75 | Rome IV | Low; High | 9.1; 6.5 | NR | 0.024 |
Cheng et al[57], 2003 | Hong Kong | 3282 | 18-80 | Rome II | Nil; < 10000; 10000-19999; 20000-29999; 30000-39999; 40000-49999; > 50000 | 13.6; 14.8; 12.5; 12.6; 12.5; 12.5; 13.1 | NR | NR |
Jun et al[58], 2006 | South Korea | 1029 | > 15 | Rome II | < 1000; 1010-2000; 2010-3000; 3010-4000; > 4010 | 16; 15; 20; 26; 24 | NR | 0.044 |
Bytzer et al[82], 2001 | Australia | 8185 | > 18 | Rome II | 5th quintile (lowest); 4th quintile; 3rd quintile; 2nd quintile; 1st quintile (highest) | 10.2; 10.3; 9.6; 8.7; 6.3 | NR | NR |
Calculated from data published.
Note: Income is stated in various currencies. NR: Not reported; NS: Not significant.
For chronic constipation, a Canadian study showed evidence of an inverse relationship[45] but this was not the case in a United States study[68]. In Iran and Brazil, there was significantly higher prevalence in those with lower income[52,66] but there was no inverse relationship in South Korea[58] and Hong Kong[57]. An inverse relationship was also reported in an Australian study[82].
For any constipation, an inverse relationship was seen in the United Kingdom, Germany, Brazil, Colombia and China, but no such trend was evident in France, Italy, South Korea and Indonesia[59,61,75]. North American studies indicate that the prevalence of any constipation increases as income decreases[38,61].
Educational level
The association of educational level and constipation is not clear with studies in various countries showing mixed results (Table 4).
Table 4.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Educational level | Prevalence (%) | Odds ratio (95%CI) | P value |
Everhart et al[67], 1989 | United States | 11204 | 25-74 | Self-report (NTP) | > 8 yr; 9-11 yr; > 12 yr | NR | 2.78; 1.35; 1 | NR |
Talley et al[49], 1993 | United States | 690 | 30-64 | Rome I | < HS; HS; > HS | 23.3; 18.4; 18.0 | NR | NR |
Stewart et al[68], 1999 | United States | 10018 | > 18 | Rome II | < 12 yr; 12 yr; 13-15.9 yr; > 16 yr | NR | 1; 1.49; 1.41; 1.39 | NR |
Pare et al[45], 2001 | Canada | 1149 | > 18 | Self-report (3 mo) | Grade school; Some HS; HS; Diploma; Tech school; Some college; College; Grad school | 28.8; 35.1; 24.6; 29.4; 20.5; 25.4; 31.5; 19.6 | NR | NR |
Pare et al[45], 2001 | Canada | 1149 | > 18 | Rome I | Grade school; Some HS; HS; Diploma; Tech school; Some college; College; Grad school | 14.3; 23.8; 18.8; 22.1; 15.0; 9.9; 17.2; 11.3 | NR | NR |
Pare et al[45], 2001 | Canada | 1149 | > 18 | Rome II | Grade school; Some HS; HS; Diploma; Tech school; Some college; College; Grad school | 4.3; 21.7; 18.6; 18.4; 12.0; 8.6; 6.5; 10.0 | NR | NR |
Wald et al[61], 2008 | United States | 2000 | > 15 | Self-report (12 mo) | < Secondary; Secondary; Tertiary | 24.7; 18.9; 15.4 | 1.82 (1.16, 2.86) | < 0.01 |
Choung et al[83], 2007 | United States | 3022 | 20-95 | BDQ | < HS; HS/College; > College | NR | 1.3 (0.5, 3.1); 1.0; 0.8 (0.5, 3.1) | NS |
Chang et al[46], 2007 | United States | 523 | 30-64 | Rome III | < HS; HS/College; > College | 16.7; 19.8; 14.8 | 0.81 (0.27, 2.46);1.00; 0.70 (0.43, 1.14) | NR |
Choung et al[65], 2012 | United States | 2853 | > 20 | Rome II | < HS; HS/College; > College | 7.0; 26.5; 20.3 | NR | 0.002 |
Wald et al[61], 2008 | United Kingdom | 2000 | > 15 | Self-report (12 mo) | < Secondary; Secondary; Tertiary | 9.4; 7.0; 7.3 | NR | NR |
Wald et al[61], 2008 | France | 2000 | > 15 | Self-report (12 mo) | < Secondary; Secondary; Tertiary | 17.6; 13.0; 12.7 | 1.48 (1.01, 2.15) | < 0.05 |
Wald et al[61], 2008 | Germany | 2000 | > 15 | Self-report (12 mo) | < Secondary; Secondary; Tertiary | 5.6; 5.5; 4.5 | NR | NR |
Enck et al[75], 2016 | Germany | > 18 | Self-report (12 mo) | < Secondary; Secondary; Tertiary | 19.6; 15.3; 15.6 | NR | < 0.001 | |
Ebling et al[50], 2014 | Croatia | 658 | 20-69 | Rome III | < Elementary; Elementary; High school; Bachelor; University | 50.0; 25.6; 20.2; 23.0; 23.4 | 0.278; 0.229; 0.248; 0.383 | 0.065; 0.028; 0.060; 0.178 |
Wald et al[61], 2008 | Italy | 2000 | > 15 | Self-report (12 mo) | < Secondary; Secondary; Tertiary | 8.0; 8.1; 6.0 | NR | NR |
Papatheodoridis et al[51], 2010 | Greece | 1000 | 15-64 | Rome III or self-report (12 mo) | Primary or less; Secondary; Higher | 18; 14; 17 | NR | 0.31 |
Rey et al[55], 2014 | Spain | 1500 | > 18 | Rome III | Primary Secondary; University | 19; 18; 20 | NR | NR |
Garrigues et al[60], 2004 | Spain | 349 | 18-65 | Self-report (12 mo) | Basic; Primary Secondary or more | 31.4; 26.4; 30.3 | NR | NS |
Wald et al[59], 2010 | Argentina | 2000 | > 15 | Self-report (12 mo) | < Secondary; Secondary; Tertiary | 15.1; 13.4; 14.8 | NR | NR |
Wald et al[59], 2010 | Colombia | 2000 | > 15 | Self-report (12 mo) | < Secondary; Secondary; Tertiary | 25.2; 21.0; 24.5 | NR | NR |
Wald et al[59], 2010 | Brazil | 2000 | > 15 | Self-report (12 mo) | < Secondary; Secondary; Tertiary | 17.0; 15.2; 26.5 | 0.58 (0.36, 0.92) | < 0.03 |
Wald et al[59], 2010 | China | 2100 | 15-60 | Self-report (12 mo) | < Secondary; Secondary; Tertiary | 10.2; 16.5; 14.4 | NR | NR |
Wald et al[59], 2010 | Indonesia | 2000 | > 15 | Self-report (12 mo) | < Secondary; Secondary; Tertiary | 10.6; 13.2; 19.0 | NR | NR |
Wald et al[59], 2010 | Korea | 2000 | > 15 | Self-report (12 mo) | < Secondary; Secondary; Tertiary | 18.1; 16.7; 16.0 | NR | NR |
Cheng et al[57], 2003 | Hong Kong | 3282 | 18-80 | Rome II | Nil; Primary; Junior HS; HS; Matriculation; University | 14.5; 12.2; 14.8; 12.6; 14.0; 14.1 | NR | NR |
Sorouri et al[53], 2010 | Iran | 18180 | NR | Rome III | Illiterate; < Diploma; HS diploma; University; > Masters | 2.9; 2.1; 2.5; 2.1; 1.6 | NR | NR |
Moezi et al[52], 2018 | Iran | 9264 | 40-75 | Rome IV | Illiterate; Other | 9.0; 7.2 | NR | 0.002 |
Howell et al[48], 2006 | Australia | 1673 | 25-64 | Rome II | Low; Low-mid; Mid-upper; High | 30.6; 31.6; 38.9; 25.1 | 1.50 (0.97, 2.31); 1.49 (1.02, 2.18); 1.91 (1.33, 2.73)1 | 0.07; 0.04; 0.001 |
Calculated from published data.
HS: High school; BDQ: Bowel disease questionnaire (similar to Rome criteria); NR: Not reported; NS: Not significant.
In studies of chronic constipation, there was evidence of an inverse relationship, i.e., higher prevalence of constipation in those with lower levels of education, in United States, Chinese, Croatian and Iranian studies[41,49,50,52,53,83] but in other studies, there was no clear evidence of this or any other trend[45,46,51,55,57,65,68].
Most North American studies[38,45,61,67] have shown an inverse relationship between prevalence of any constipation and years of education. In studies of any constipation in other countries, both trends were observed; in the United Kingdom, France, Germany, Italy and South Korea[61,75], there was an inverse relationship between any constipation and educational level but the opposite was found in Brazil, China and Indonesia[59,61]. No trends were found in Spain, Argentina and Colombia[59,60].
Residential region within countries
The prevalence of constipation appears to vary by residential region within some countries (Table 5). Significant differences in the prevalence of any constipation have been observed in China between different regions and between rural and urban locations, with a significantly higher prevalence in rural areas[41]. However, in Croatia there was a significantly higher prevalence of chronic constipation in urban populations[50]. Regional differences have also been reported for any constipation in Canada and Greece[45,51] and in Spain for chronic constipation[55].
Table 5.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Region of residence | Prevalence (%) | Odds ratio (95%CI) | P value |
Pare et al[45], 2000 | Canada | 1149 | > 18 | Self-report (3 mo) | Atlantic; Quebec; Ontario; Prairies; British Columbia | 26.7; 25.8; 26.7; 25.6; 32.3 | NR | NR |
Pare et al[45], 2000 | Canada | 1149 | > 18 | Rome I | Atlantic; Quebec; Ontario; Prairies; British Columbia | 18.2; 22.1; 13.5; 16.4; 14.5 | NR | NR |
Pare et al[45], 2000 | Canada | 1149 | > 18 | Rome II | Atlantic; Quebec; Ontario; Prairies; British Columbia | 15.9; 18.6; 13.7; 14.0; 11.9 | NR | NR |
Papatheodoridis et al[51], 2010 | Greece | 1000 | 15-64 | Rome III or self-report (12 mo) | Athens; Thessaloniki; Other cities | 13; 18; 19 | 0.581 (0.399, 0.844); 0.928 (0.539, 1.598);1.0 | 0.004; 0.787; 0.017 |
Rey et al[55], 2014 | Spain | 1500 | > 18 | Rome III | Mediterranean; Centre; Atlantic | 21; 17; 15 | NR | NR |
Rey et al[55], 2014 | Spain | 1500 | > 18 | Rome III | Urban; Rural | 20; 18 | NR | NR |
Ebling et al[50], 2014 | Croatia | 658 | 20-69 | Rome III | Urban; Rural | 22.2; 17.5 | 1.947 | 0.003 |
Chu et al[41], 2014 | China | > 18 | Rome II | Hong Kong; Mainland | 14.0; 6.4 | NR | < 0.001 | |
Chu et al[41], 2014 | China | > 18 | Rome II | North; South | 15.5; 3.3 | NR | < 0.001 | |
Chu et al[41], 2014 | China | > 18 | Rome II | East; Midwest | 4.0; 11.0 | NR | < 0.001 | |
Chu et al[41], 2014 | China | > 18 | Rome II | Urban; Rural | 6.7; 7.2 | NR | < 0.001 |
Calculated from data published. NR: Not reported.
Other demographic and socioeconomic factors
The association of work or employment status and constipation is not clear with studies in various countries showing mixed results (Table 6). In Germany, there appears to be an increased prevalence of any constipation in those not working[75] but in North America chronic constipation seems to be more prevalent in those working[45,49].
Table 6.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Factor | Variable | Prevalence (%) | Odds ratio (95%CI) | P value |
Talley et al[49], 1993 | United States | 690 | 30-64 | Self-report; Rome I | Marital status | Married; Not married | 17.8; 22.1 | NR | NR |
Chang et al[46], 2007 | United States | 523 | 30-64 | Rome III | Marital status | Married; Single; Other | 17.2; 23.1; 19.1 | 1.0; 1.27 (0.46, 3.48); 1.07 (0.53, 2.16) | NS |
Choung et al[83], 2007 | United States | 3022 | 20-95 | BDQ | Marital status | Married; Not married | 16; 22 | 0.8 (0.5, 1.2); 1.0 | NS |
Rey et al[55], 2014 | Spain | 1500 | > 18 | Rome III | Marital status | Married; Single; Other | 20; 16; 22 | NR | NR |
Ebling et al[50], 2014 | Croatia | 658 | 20-69 | Rome III | Marital status; House; hold size | Divorced; Large size | 35.7; NR | 2.91; 1.19 | 0.039; 0.01 |
Sorouri et al[53], 2010 | Iran | 18180 | NR | Rome III | Marital status | Married; Single; Widowed; Divorced | 3.5; 0.7; 8.8; 12.5 | NR | NR |
Moezi et al[52], 2018 | Iran | 9264 | 40-75 | Rome IV | Marital status | Divorced or Widowed | 12.9 | NR | < 0.001 |
Pare et al[45], 2000 | Canada | 1149 | > 18 | Self-report (3 mo) | Work status | Employed; Unemployed; Retired | 27.2; 23.4; 25.5 | NR | NR |
Pare et al[45], 2000 | Canada | 1149 | > 18 | Rome I | Work status | Employed; Unemployed; Retired | 16.3; 9.2; 15.0 | NR | NR |
Pare et al[45], 2000 | Canada | 1149 | > 18 | Rome II | Work status | Employed; Unemployed; Retired | 14.1; 5.7; 16.2 | NR | NR |
Talley et al[49], 1993 | United States | 690 | 30-64 | Rome I | Work status | Employed; Unemployed | 20.1; 12.0 | NR | NR |
Enck et al[75], 2016 | Germany | 15002 | > 18 | Self-report (12 mo) | Work status | Full-time; Part-time; Unemployed | 10.81; 13.31; 18.31 | NR | < 0.001 |
Drossman et al[44], 1993 | United States | 5430 | > 15 | Rome I | Ethnicity | White; Other | NR | 0.54 (0.3, 0.9) | NR |
Calculated from data published.
NR: Not reported; NS: Not significant; BDQ: Bowel disease questionnaire (similar to Rome criteria).
Similarly, the association of marital status and constipation is not clear but there may be a tendency for a lower prevalence of chronic constipation in those who are married (Table 6).
One United States study has shown a lower prevalence of chronic constipation in white participants compared to other ethnic groups[44]. Ethnicity differences have also been reported in China[41].
LIFESTYLE AND BEHAVIOURAL FACTORS
The following section describes lifestyle and behavioural factors potentially associated with constipation in adults in community settings.
Physical activity
There is limited evidence that low levels of physical activity and physical inactivity are associated with a high prevalence of constipation. Low levels of exercise/physical activity were significantly associated with increasing rates of both chronic[52,55] and any constipation[60,61] in studies conducted in various countries (Table 7).
Table 7.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Physical activity status | Prevalence (%) | Odds ratio (95%CI) | P value |
Garrigues et al[60], 2004 | Spain | 349 | 18-65 | Self-report (12 mo) | Never; Sometimes; Habitually | 23.2; 10.9; 7.4 | 1.00; 0.43 (0.20, 0.89); 0.31 (0.11, 0.87) | 0.02; 0.03 |
Rey et al[55], 2014 | Spain | 1500 | > 18 | Rome III | Regular sport; Long walks; Short walks; No regular walk | 14; 16; 24; 30 | 1.00; 0.97 (0.66, 1.43); 1.52 (1.06, 2.19); 2.04 (1.23, 3.39) | < 0.01 |
Wald et al[61], 2008 | United States, United Kingdom, France, Germany, Italy, Brazil and South Korea | 14000 | > 15 | Self-report (12 mo) | Active; Reduced activity | NR | 1.00; 1.23 (1.07, 1.40) | < 0.05 |
Moezi et al[52], 2018 | Iran | 9264 | 40-75 | Rome IV | Low; Medium; High | 10.91; 7.81; 5.61 | 1.00; 0.74 (0.62, 0.89); 0.56 (0.46, 0.68) | < 0.001 |
Calculated from data published. NR: Not reported.
Smoking
Conflicting data indicates that there is no clear association of smoking with the prevalence of chronic or any constipation (Table 8). United States and Iranian studies[52,83] have suggested that smoking may be a possible risk factor in chronic constipation. However other United States studies[46,65] and studies in Greece and Taiwan[51,56] found no significant differences in the prevalence of chronic constipation in smokers and non-smokers. Furthermore, one United States study[49] and one study in Norway[71] found that smoking was a negative risk factor for chronic and any constipation respectively.
Table 8.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Smoking status | Prevalence (%) | Odds ratio (95%CI) | P value |
Choung et al[65], 2012 | United States | 2853 | > 20 | Rome II | Current smoker | 26.3 | NR | NS |
Choung et al[83], 2007 | United States | 7805 | 20-95 | BDQ | Non-smoker; Smoker | 16; 20 | 1.00; 1.40 (0.7, 2.7) | NS |
Talley et al[49], 1993 | United States | 690 | 30-64 | Rome I | No cigarettes; > 15/d | 20.9; 12.3 | 4.7 (1.6, 13.7) | < 0.05 |
Chang et al[46], 2007 | United States | 523 | 30-64 | Rome III | Never; Current; Past; Ever | 18.9; 17.3; 17.0; 17.1 | 1.0; 0.90 (0.47, 1.73); 0.88 (0.53, 1.45); 0.89 (0.57, 1.39) | NS |
Haug et al[71], 2002 | Norway | 62651 | > 20 | Self-report (12 mo) | Non-smoker; Smoker | NR; NR | 1.00; 0.83 | NR |
Papatheodoridis et al[51], 2010 | Greece | 1000 | 15-64 | Rome III or self-report (12 mo) | Active; Inactive | 16; 16 | NR | 0.98 |
Lu et al[56], 2006 | Taiwan | 2018 | > 20 | Rome II | Non-smoker; Smoker | 8.81; 6.51 | NR | NS |
Calculated from data published.
NR: Not reported; NS: Not significant; BDQ: Bowel disease questionnaire (similar to Rome criteria).
Fibre
There is little evidence that low fibre intake is associated with a high prevalence of either chronic or any constipation (Table 9). In one Spanish study, both low and high fibre intakes were associated with increased prevalence of any constipation[60] and in another Spanish study there was no significant association with chronic consti-pation[55].
Table 9.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Dietary intake of fibre | Prevalence (%) | Odds ratio (95%CI) | P value |
Garrigues et al[60], 2004 | Spain | 349 | 18-65 | Self-report (12 mo) | Low fibre; Medium fibre; High fibre | 19.2; 10.9; 20.9 | 1.00; 0.38 (0.15, 0.96); 1.05 (0.35, 3.17) | 0.04; 0.93 |
Rey et al[55], 2014 | Spain | 1500 | > 18 | Rome III | 1st quintile; 2nd quintile; 3rd quintile; 4th quintile; 5th quintile | 23; 18; 17; 18; 20 | NR | NS |
NR: Not reported; NS: Not significant.
Fluid
There is little evidence that fluid intake is associated with the prevalence of chronic or any constipation (Table 10). The only evidence occurred in one Spanish study where chronic constipation was inversely related to fluid intake, defined as glasses of liquids consumed daily[55]. One United States study showed no association of coffee with chronic constipation[46].
Table 10.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Fluid intake per day | Prevalence (%) | Odds ratio (95%CI) | P value |
Rey et al[55], 2014 | Spain | 1500 | > 18 | Rome III | 7 glasses or less; 8-9 glasses; 10-11 glasses; 12-14 glasses; 15 glasses or more | 21; 20; 19; 18; 16 | NR | < 0.01 |
Chang et al[46], 2007 | United States | 523 | 30-64 | Rome III | No coffee; Coffee | 18.7; 17.8 | 1.00; 0.94 (0.5, 1.77) | NS |
NR: Not reported; NS: Not significant.
Alcohol
There is limited evidence that alcohol consumption may be associated with a decreased prevalence of chronic constipation (Table 11).
Table 11.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Weekly alcohol consumption | Prevalence (%) | Odds ratio (95%CI) | P value |
Choung et al[83], 2007 | United States | 7805 | 20-95 | BDQ | No alcohol; Alcohol | 16; 17 | 1; 1.1 (0.7, 1.7) | NS |
Talley et al[49], 1993 | United States | 690 | 30-64 | Rome I | No alcohol; > 7 drinks | 19.7; 9.41 | 3.6 (1.2, 10.4) | < 0.05 |
Chang et al[46], 2007 | United States | 523 | 30-64 | Rome III | 0 drinks; 1-2; 3-6; > 7; Any alcohol | 19.3; 19.2; 14.1; 14.9; 16.3 | 1.0; 0.99 (0.55, 1.79); 0.69 (0.34, 1.39); 0.73 (0.35, 1.53); 0.82 (0.52, 1.29) | NS |
Fosnes et al[54], 2011 | Norway | 4622 | 31-76 | Rome II | > Once; < Once | 10.61; 14.21 | 0.94 (0.89, 0.99) | 0.024 |
Choung et al[65], 2012 | United States | 2853 | > 20 | Rome II | 1-6 drinks; 7+ drinks | 25.31; 23.11 | NR | NS |
Moezi et al[52], 2018 | Iran | 9264 | 40-75 | Rome IV | No alcohol; Alcohol | 7.91; 9.71 | NR | NS |
Lu et al[56], 2006 | Taiwan | 2018 | > 20 | Rome II | No alcohol; Alcohol | 8.91; 7.41 | NR | NS |
Calculated from data published.
NR: Not reported; NS: Not significant; BDQ: Bowel disease questionnaire (similar to Rome criteria).
Several studies have investigated the association of alcohol and chronic constipation. Increasing alcohol intake was a negative risk factor for chronic constipation in a United States study[49] and also in a Norwegian study[54]. A similar trend was observed in Taiwan[56] and other United States studies, but the opposite trend was found in Iran, but no relationships reached significance[46,52,56,83].
HEALTH-RELATED FACTORS
The following section describes health-related factors potentially associated with constipation in adults in community settings.
Self-rated health
Fair or poor self-rated health was significantly associated with an increased prevalence of chronic constipation in two European studies[50,75] (Table 12).
Table 12.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Self-rated health | Prevalence (%) | Odds ratio (95%CI) | P value |
Ebling et al[50], 2014 | Croatia | 658 | 20-69 | Rome III | Lower | NR | 0.628 | < 0.001 |
Enck et al[75], 2016 | Germany | 15002 | > 18 | Self-report (12 mo) | Very good; Good; Satisfactory; Less good; Bad | 9.11; 12.21; 18.41; 22.11; 28.21 | NR | < 0.001 |
Calculated from data published. NR: Not reported.
Medical conditions
Various medical conditions have been reported to be potentially associated with constipation in epidemiological studies (Table 13).
Table 13.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Condition | Prevalence (%) | Odds ratio (95%CI) | P value |
Schmidt et al[66], 2016 | Brazil | 2162 | > 18 | Rome III | Fistula; Haemorrhoids; Anal fissures; Nervous disease; Stroke | 54.5; 29.3; 35.8; 24.5; 48.3 | 3.8 (1.5, 9.7); 1.9 (1.3, 2.7); 2.2 (1.3, 3.6); 1.6 (1.1, 2.1); 5.3 (2.3, 12.1) | NR |
Cheng et al[57], 2003 | Hong Kong | 3282 | 18-80 | Rome II | Anxiety; Depression | NR | NR | < 0.0001; < 0.0001 |
Koloski et al[84], 2002 | Australia | 2910 | > 18 | Rome I | Anxiety; Depression | 5.6; 4.2 | NR | < 0.05; < 0.05 |
Bytzer et al[86], 1989 | Australia | 8185 | > 18 | BDQ | Control; Diabetes mellitus | 9.2; 11.4 | 1.00; 1.54 | NR |
Choung et al[69], 2016 | United States | 2327 | > 25 | Rome III | Rectal cancer; Neurological dis; Parkinson’s dis; Multiple sclerosis; Metabolic dis; Cardiovascular dis; Angina; Psychiatric disorder | NR | 4.7 (1.0, 22.2); 1.5 (1.1, 1.9); 6.5 (2.9, 14.4); 5.5 (1.9, 15.8); 1.4 (1.1, 1.9); 1.5 (1.1, 1.9); 1.4 (1.1, 1.9); 1.3 (1.0, 1.7) | NR |
Choung et al[65], 2012 | United States | 2853 | > 20 | Rome II | Dyspepsia; GORD | 46.9; 34.3 | NR; NR | < 0.01; < 0.01 |
Enck et al[75], 2016 | Germany | 15002 | > 18 | Self-report (12 mo) | Back pain; Circulation problem; Gynecological; Urological; Gastrointestinal | 19.01; 25.21; 35.11; 34.31; 31.61 | NR | < 0.001 < 0.001; < 0.001 < 0.001; < 0.001 |
Ebling et al[50], 2014 | Croatia | 658 | 20-69 | Rome III | BMI; Anemia | NR; 40.0 | 1.051; NR | 0.777; < 0.01 |
Chang et al[46], 2007 | United States | 523 | 30-64 | Rome III | BMI 1st Q; BMI 2nd Q; BMI 3rd Q; BMI 4th Q | 19.4; 13.6; 18.0; 20.7 | 1.0; 0.65 (0.32, 1.32); 0.92 (0.46, 1.82); 1.07 (0.55, 2.10) | NS |
Rey et al[55], 2014 | Spain | 1500 | > 18 | Rome III | Normal; Overweight; Obese | 22; 15; 20 | NR | NR |
Papatheodoridis et al[51], 2010 | Greece | 1000 | 15-64 | Rome III or self-report (12 mo) | Underweight; Normal weight; Overweight; Obese | 18; 14; 17; 20 | NR | 0.21 |
Pourhoseingholi et al[85], 2008 | Iran | 2547 | NR | Self-report (NTP) | BMI < 25; BMI 25-30; BMI > 30 | 40.4; 38.9; 40.7 | NR | NS |
Haug et al[71], 2002 | Norway | 60998 | > 20 | Self-report (12 mo) | Anxiety; Depression | NR; NR | 1.86 (1.67, 2.07); 1.46 (1.30, 1.65) | NR |
Fosnes et al[54], 2011 | Norway | 4622 | 31-76 | Rome II | BMI; M/S complaints; Angina; MS | NR | 0.95 (0.93, 0.97); 1.04 (1.002, 1.09); 1.86 (1.21, 2.85); 2.14 (1.03, 5.66) | < 0.001; 0.042; 0.004; 0.043 |
Lu et al[56], 2006 | Taiwan | 2018 | > 20 | Rome II | Diabetes; Hypertension | 14.11;11.11 | NR | NS; NS |
Moezi et al[52], 2018 | Iran | 9264 | 40-75 | Rome IV | Insomnia; Anxiety; Depression; Back or joint pain; GORD | 13.51; 11.71; 12.41; 9.41; 11.71 | 1.62 (1.36, 1.93); 1.38 (1.15, 1.65); 1.22 (1.01, 1.48); 1.38 (1.14, 1.67); 1.51 (1.28, 1.78) | < 0.001; < 0.001; < 0.001; < 0.001; < 0.001 |
Calculated from data published.
NR: Not reported; NS: Not significant; BDQ: Bowel disease questionnaire (similar to Rome criteria); BMI: Body mass index; M/S: Musculoskeletal; MS: multiple sclerosis; GORD: Gastroesophageal reflux disease.
Gastrointestinal disorders: In a review of co-morbidities[42], dyspepsia, heartburn, gastroesophageal reflux disease (GORD) and nausea/vomiting were commonly associated with chronic constipation. The association of GORD with constipation has been reported in several epidemiological studies[41,52,65]. Other gastrointestinal disorders including colorectal cancer and diverticulitis have also been associated with any constipation[43] and chronic constipation[65,69].
Anorectal disorders, particularly haemorrhoids, are frequently associated with constipation. A review of 7 studies conducted up to 2009[43] found a significant association between any constipation and haemorrhoids. Haemorrhoids also have been found to be commonly associated with chronic constipation[41,66]. Other anorectal disorders found to be associated with any constipation include fistulas, anal fissures and rectal prolapse[43,66].
Depression, anxiety and insomnia: There is evidence that depression and anxiety are associated with chronic and any constipation, and limited evidence for insomnia.
In a review of comorbidities, depression was the most commonly reported psychiatric condition associated with chronic constipation, occurring in 15% to 29% of chronic constipation patients[42]. In other studies not included in the review, depression and anxiety were found to be significantly associated with both chronic or any constipation[52,57,71,84]; one of these studies also found insomnia to be significantly associated with chronic constipation[52].
Neurological diseases: Odds ratios for chronic constipation in multiple sclerosis have been reported to be 5.5[69] and 2.41[54] in two studies; chronic constipation in Parkinson’s disease had an odds ratio of 6.5[69].
Obesity: There is conflicting evidence of any association of obesity or body weight with chronic or any constipation.
In a review of comorbidities, chronic constipation was frequently associated with obesity (20% to 37% of chronic constipation patients) and being overweight (17% to 40% of chronic constipation patients)[42]. However, other epidemiological studies have found no clear association between body mass index (BMI) and chronic or self-reported constipation[46,50-52,55,65,85].
Other medical conditions: In a review of comorbidities, diabetes was found to be frequently associated with chronic constipation (4.7% to 11.8% of chronic constipation patients) in a comorbidity review[42]. Some, but not all, epidemiological studies have also reported this association[56,69,86].
For chronic constipation, constipation with cardiovascular disease had an odds ratio of 1.5 in one study[69]. In the same study, the odds ratio for constipation in angina was 1.4 and in another study it was 1.86[54]. Stroke was associated with chronic constipation in Brazilian study[66]. Musculoskeletal complaints were found to be associated with chronic constipation[54], including back or joint pain[52]. Urinary tract disorders have also been reported to be associated with constipation[43].
Surgery
Recent surgery is well-known to be a risk factor for constipation; this may be associated with medications including general anaesthetics and opioid analgesics as well as being sedentary following surgery. However, the long-term effects of different surgical procedures may contribute to chronic constipation. Gynaecological, abdominal and anorectal surgery were significantly associated with an increased risk of chronic constipation in four epidemiological studies[53,66,69,83] but cholecystectomy and appendectomy were not significant in others[56,65] (Table 14).
Table 14.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Surgery | Odds ratio (95%CI) | P value |
Choung et al[83], 2007 | United States | 7805 | 20-95 | BDQ | Abdominal | 1.2 (0.7, 2.0) | NS |
Choung et al[69], 2016 | United States | 2327 | > 25 | Rome III | Anorectal surgery; Hysterectomy | 3.3 (1.2, 9.1); 1.5 (1.0, 2.2) | 0.02; 0.033 |
Schmidt et al[66], 2016 | Brazil | 2162 | > 18 | Rome III | Anorectal surgery | 5.3 (2.3, 12.1) | NR |
Lu et al[56], 2006 | Taiwan | 2018 | > 20 | Rome II | Appendectomy; Cholecystectomy; Hysterectomy | NR | NS; NS; NS |
Sorouri et al[53], 2010 | Iran | 18180 | NR | Rome III | Abdominal surgery | 0.66 (0.52, 0.83) | < 0.01 |
NR: Not reported; NS: Not significant; BDQ: Bowel disease questionnaire (similar to Rome criteria).
Medications
Constipation is a common side effect of many drug classes[87,88] but this is not always evident in population-based studies because few have reported concomitant drug use.
The number of medications used may be associated with chronic or any constipation. In a Norwegian study[54], the use of one or more medications was found to be associated with chronic constipation (Table 15). Aspirin and non-steroidal anti-inflammatory drugs (NSAIDs), particularly ibuprofen, were significantly associated with chronic constipation in this and other studies[46,49,54] (Table 16). Other classes of drugs including digoxin, glyceryl trinitrate, atorvastatin, furosemide and levo-thyroxine have also been found to be significantly associated with chronic constipation[54].
Table 15.
Ref. | Location | Sample size | Age | Definition of constipation | Number of drugs taken | Odds ratio (95%CI) | P value |
Fosnes et al[54], 2011 | Norway | 4622 | 31-76 | Rome II | 0; 1; 2-3; 4 or more | 1; 1.34 (1.07, 1.69); 1.26 (0.99, 1.61); 1.21 (0.85, 1.71) | 0.012; 0.062; 0.288 |
Table 16.
Ref. | Location | Sample size | Age range (yr) | Definition of constipation | Medications | Prevalence (%) | Odds ratio (95%CI) | P value |
Fosnes et al[54], 2011 | Norway | 4622 | 31-76 | Rome II | Digoxin; GTN; Furosemide; Atorvastatin; Tibolone; Levothyroxine; Ibuprofen | NR | NR | 0.025; 0.015; 0.001; 0.037; 0.038; < 0.001; 0.001 |
Talley et al[49], 1993 | United States | 690 | 30-64 | Rome I | Aspirin > 7 tabs/wk | 31.1 | 2.6 (1.2, 5.7) | < 0.05 |
Chang et al[46], 2007 | United States | 523 | 30-64 | Rome III | Paracetamol; Aspirin; NSAIDs | 25.3; 23.0; 26.6 | 1.50 (0.91, 2.47) 1.67 (1.04, 2.70) 1.80 (1.09, 2.98) | NS; < 0.05; < 0.05 |
GTN: Glyceryl trinitrate; NSAIDs: Non-steroidal anti-inflammatory drugs; NR: Not reported; NS: Not significant.
DISCUSSION
This is the first comprehensive review of epidemiological studies of community populations to present a detailed assessment of real-world evidence relating to all possible potential risk factors for defined adult constipation. This review of studies spanning 30 years of research identified many factors considered to be potentially associated with constipation in community-dwelling adults. These studies frequently refer to these factors as risk factors or potential risk factors for constipation. A risk factor is any factor which is proven to cause an increased prevalence of a disease but in cross-sectional studies only associations can be identified[89]. There are two issues to consider in determining the association of any factor with the prevalence of constipation in population-based studies. Firstly, the studies investigating factors associated with constipation have been cross-sectional which precludes any links to causality[89]. Factors identified as being associated with constipation could be potential risk factors, or they could be caused by constipation or both. For example, factors such as poor self-rated health, haemorrhoids and depression may be either risk factors for constipation or these factors could be resulting from constipation itself. In the case of haemorrhoids, it is hypothesized that the straining of constipation leads to the development of haemorrhoids[43]. Secondly, published cross-sectional studies investigating factors associated with constipation have tended to focus on a small number of factors of interest, ignoring other factors which may be confounding variables. For example, drugs used by participants may cause constipation as a side effect and this may influence the results obtained. If a wide range of factors is not studied, the possibility of confounding bias exists and diminishes the value of the results[90]. In the period of this review, there has been no comprehensive epidemiological study which has investigated a wide range of associated factors in the same population sample. In addition, many early studies have assessed factors only on univariate analysis, not multivariate, and therefore have not taken all confounding variables into account when determining which factors are associated with constipation.
In assessing the results of studies reviewed, it is clear that there is insufficient evidence for an association of most factors with constipation (Table 17). Regarding demographic factors, female gender is strongly associated with an increased prevalence of constipation; there are various possible explanations for this such as the influence of sex hormones[40]. There is no clear evidence that increasing age is associated with increased constipation. Contrary to widespread beliefs, many epidemiological studies show higher prevalence of constipation in younger age groups. Whilst increasing age effects may be explained by anatomical changes or medications[40], there is no obvious explanation for the high prevalence of constipation in younger adults. Geographic location within a country may be associated with constipation and there are indications that ethnicity may also be associated, however there are conflicting data regarding marital status. The data for socioeconomic factors such as income levels, educational levels and work status are conflicting and appear to vary by country. Similarly, the data for lifestyle factors is mixed. Whilst there is evidence that low physical activity levels are associated with constipation, there is only limited evidence for low fluid intakes and no evidence for low fibre intakes. The effects of smoking, alcohol, and coffee on constipation are unclear and could not be confirmed in this review. However, it is clear that some health-related factors are associated with constipation. This includes low self-rated health, some surgical procedures, some medications, and various medical conditions including depression, haemorrhoids, neurological diseases and some gastrointestinal, cardiovascular and musculoskeletal disorders.
Table 17.
Category
|
Factor
|
Association with constipation
|
Demographic | Age | Conflicting data, probably only > 70 yr |
Female gender | Associated | |
Income level | Conflicting data, probably country specific | |
Educational level | Conflicting data, probably country specific | |
Residential location | Associated | |
Work status | Conflicting data | |
Marital status | Conflicting data | |
Ethnicity | Possible association | |
Lifestyle | Physical activity | Associated |
Fibre | No evidence for low fibre | |
Fluid | Possible association | |
Smoking | Conflicting data | |
Alcohol | No clear evidence | |
Coffee | No association | |
Health-related | Self-rated health | Associated |
Obesity | Conflicting data | |
Depression | Associated | |
Anorectal | Associated – haemorrhoids and other conditions | |
Gastrointestinal | Associated | |
Neurological | Associated – MS, Parkinson’s disease | |
Endocrine | Associated - diabetes | |
Cardiovascular | Associated | |
Musculoskeletal | Associated | |
Surgery | Associated – gynaecological, anorectal, abdominal | |
No. of medications | Possible association | |
NSAIDs | Associated | |
Aspirin | Associated | |
Other drugs | Possible association |
NSAIDs: Non-steroidal anti-inflammatory drugs; MS: Multiple sclerosis.
Further research is required to comprehensively assess each of these factors. There are many variations and complexities involved in the epidemiological studies conducted to date. Firstly, differences in population samples, study designs, data collection methods and analyses may contribute to the different results obtained. Also, results may be affected by differences in the constipation definition – different criteria used to define chronic or any constipation[3]. Similarly, different criteria used to define comorbid conditions will affect results[42]. When considering comorbid conditions, it is possible that medications being used as treatment may be causing, wholly or in part, the constipation. This could certainly be the case in conditions such as depression, musculoskeletal disorders and cardiovascular diseases where constipation is a known side effect of many medications used for treatment[87,88]. Any increased prevalence of constipation with age may be more related to secondary causes such as comorbid conditions and medications[91]. Most constipation management protocols recommend increases in dietary fibre, fluid intake and physical activity[9,92,93]; there is the possibility that any studies showing high levels of these factors being associated with high constipation prevalence may be indicating that these are consequences of constipation management rather than risk factors for constipation.
This comprehensive and contemporary review of studies conducted in community settings extends earlier work that questioned the existence of real-world evidence for potential risk factors of constipation[4,5]. The strengths of this review are the restriction to population-based studies of community-dwelling adults and the restriction to studies where defined constipation (any or chronic), rather than stool characteristics, was assessed. Also this review was restricted to cross-sectional surveys of the community and excluded studies of convenience samples such as patient or employee groups which were considered not to reflect community settings. One limitation is the risk of bias because only articles published in English were reviewed which may have restricted studies of non-white populations. However, earlier reviews reported a lack of available data from developing countries[7,36].
CONCLUSION
Apart from female gender, residential location, physical activity and some health-related factors, it is unclear whether most other potential risk factors are associated with constipation because of insufficient evidence or conflicting data. In view of the complexities involved in previous research, it is essential that further research is conducted in community-dwelling adult populations to better understand the importance of each risk factor in constipation. It is recommended that a broad range of factors be investigated in same population samples using multivariate analysis to uncover which factors are associated with any constipation or chronic constipation in the community.
ACKNOWLEDGEMENTS
The authors acknowledge guidance received from Associate Professor Murray Fisher, University of Sydney, and Associate Professor Lisa Pont and Professor Kylie Williams, University of Technology Sydney.
Footnotes
Conflict-of-interest statement: The authors declare no conflict of interest regarding publication of this review.
Manuscript source: Invited manuscript
Peer-review started: January 27, 2021
First decision: February 27, 2021
Article in press: April 26, 2021
Specialty type: Gastroenterology and hepatology
Country/Territory of origin: Australia
Peer-review report’s scientific quality classification
Grade A (Excellent): 0
Grade B (Very good): B
Grade C (Good): C
Grade D (Fair): 0
Grade E (Poor): 0
P-Reviewer: Chen F, Yurrita L S-Editor: Gong ZM L-Editor: A P-Editor: Liu JH
Contributor Information
Barry L Werth, Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney, Sydney 2006, New South Wales, Australia. barrywerth@yahoo.com.au.
Sybele-Anne Christopher, Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney, Sydney 2006, New South Wales, Australia.
References
- 1.Talley NJ. Definitions, epidemiology, and impact of chronic constipation. Rev Gastroenterol Disord . 2004;4 Suppl 2:S3–S10. [PubMed] [Google Scholar]
- 2.Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology . 2016 doi: 10.1053/j.gastro.2016.02.032. [DOI] [PubMed] [Google Scholar]
- 3.Werth BL. Epidemiology of constipation in adults: Why estimates of prevalence differ. J Epidemiol Res . 2019;5:37–49. [Google Scholar]
- 4.Müller-Lissner SA, Kamm MA, Scarpignato C, Wald A. Myths and misconceptions about chronic constipation. Am J Gastroenterol . 2005;100:232–242. doi: 10.1111/j.1572-0241.2005.40885.x. [DOI] [PubMed] [Google Scholar]
- 5.Leung FW. Etiologic factors of chronic constipation: review of the scientific evidence. Dig Dis Sci . 2007;52:313–316. doi: 10.1007/s10620-006-9298-7. [DOI] [PubMed] [Google Scholar]
- 6.Annells M, Koch T. Constipation and the preached trio: diet, fluid intake, exercise. Int J Nurs Stud . 2003;40:843–852. doi: 10.1016/s0020-7489(03)00075-0. [DOI] [PubMed] [Google Scholar]
- 7.Mugie SM, Benninga MA, Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol . 2011;25:3–18. doi: 10.1016/j.bpg.2010.12.010. [DOI] [PubMed] [Google Scholar]
- 8.Sbahi H, Cash BD. Chronic Constipation: a Review of Current Literature. Curr Gastroenterol Rep . 2015;17:47. doi: 10.1007/s11894-015-0471-z. [DOI] [PubMed] [Google Scholar]
- 9.Wald A. Constipation: Advances in Diagnosis and Treatment. JAMA . 2016;315:185–191. doi: 10.1001/jama.2015.16994. [DOI] [PubMed] [Google Scholar]
- 10.Morrison SM, Symes L. An integrative review of expert nursing practice. J Nurs Scholarsh . 2011;43:163–170. doi: 10.1111/j.1547-5069.2011.01398.x. [DOI] [PubMed] [Google Scholar]
- 11.Tuteja AK, Talley NJ, Joos SK, Woehl JV, Hickam DH. Is constipation associated with decreased physical activity in normally active subjects? Am J Gastroenterol . 2005;100:124–129. doi: 10.1111/j.1572-0241.2005.40516.x. [DOI] [PubMed] [Google Scholar]
- 12.Pamuk ON, Pamuk GE, Celik AF. Revalidation of description of constipation in terms of recall bias and visual scale analog questionnaire. J Gastroenterol Hepatol . 2003;18:1417–1422. doi: 10.1046/j.1440-1746.2003.03155.x. [DOI] [PubMed] [Google Scholar]
- 13.Santacruz CC, López MO, García MV, Pérez CF, Miguel JC. Do bad habits bring a double constipation risk? Turk J Gastroenterol . 2018;29:580–587. doi: 10.5152/tjg.2018.17533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Najafimehr H, Yadegari H, Taherinejad H, Manhoie K, Rasooli SR, Moradi A, Akbariju MJ, Mohseni H, Ghadimi S, Mohaghegh Shalmani H. The effect of working in an auto factory on functional constipation and bowel habits. Gastroenterol Hepatol Bed Bench . 2019;12:S101–S107. [PMC free article] [PubMed] [Google Scholar]
- 15.Herz MJ, Kahan E, Zalevski S, Aframian R, Kuznitz D, Reichman S. Constipation: a different entity for patients and doctors. Fam Pract . 1996;13:156–159. doi: 10.1093/fampra/13.2.156. [DOI] [PubMed] [Google Scholar]
- 16.Gage H, Kaye J, Kimber A, Storey L, Egan M, Qiao Y, Trend P. Correlates of constipation in people with Parkinson's. Parkinsonism Relat Disord . 2011;17:106–111. doi: 10.1016/j.parkreldis.2010.11.003. [DOI] [PubMed] [Google Scholar]
- 17.Ng KS, Nassar N, Hamd K, Nagarajah A, Gladman MA. Prevalence of functional bowel disorders and faecal incontinence: an Australian primary care survey. Colorectal Dis . 2015;17:150–159. doi: 10.1111/codi.12808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ballou S, Katon J, Singh P, Rangan V, Lee HN, McMahon C, Iturrino J, Lembo A, Nee J. Chronic Diarrhea and Constipation Are More Common in Depressed Individuals. Clin Gastroenterol Hepatol . 2019;17:2696–2703. doi: 10.1016/j.cgh.2019.03.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Talley NJ, Boyce PM, Owen BK, Newman P, Paterson KJ. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med . 1995;25:302–308. doi: 10.1111/j.1445-5994.1995.tb01894.x. [DOI] [PubMed] [Google Scholar]
- 20.Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol . 2003;98:1107–1111. doi: 10.1111/j.1572-0241.2003.07465.x. [DOI] [PubMed] [Google Scholar]
- 21.Arora G, Mannalithara A, Mithal A, Triadafilopoulos G, Singh G. Concurrent conditions in patients with chronic constipation: a population-based study. PLoS One . 2012;7:e42910. doi: 10.1371/journal.pone.0042910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Walter S, Hallböök O, Gotthard R, Bergmark M, Sjödahl R. A population-based study on bowel habits in a Swedish community: prevalence of faecal incontinence and constipation. Scand J Gastroenterol . 2002;37:911–916. doi: 10.1080/003655202760230865. [DOI] [PubMed] [Google Scholar]
- 23.Tamura A, Tomita T, Oshima T, Toyoshima F, Yamasaki T, Okugawa T, Kondo T, Kono T, Tozawa K, Ikehara H, Ohda Y, Fukui H, Watari J, Miwa H. Prevalence and Self-recognition of Chronic Constipation: Results of an Internet Survey. J Neurogastroenterol Motil . 2016;22:677–685. doi: 10.5056/jnm15187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Siproudhis L, Pigot F, Godeberge P, Damon H, Soudan D, Bigard MA. Defecation disorders: a French population survey. Dis Colon Rectum . 2006;49:219–227. doi: 10.1007/s10350-005-0249-8. [DOI] [PubMed] [Google Scholar]
- 25.Bassotti G, Bellini M, Pucciani F, Bocchini R, Bove A, Alduini P, Battaglia E, Bruzzi P Italian Constipation Study Group. An extended assessment of bowel habits in a general population. World J Gastroenterol . 2004;10:713–716. doi: 10.3748/wjg.v10.i5.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Sanjoaquin MA, Appleby PN, Spencer EA, Key TJ. Nutrition and lifestyle in relation to bowel movement frequency: a cross-sectional study of 20630 men and women in EPIC-Oxford. Public Health Nutr . 2004;7:77–83. doi: 10.1079/phn2003522. [DOI] [PubMed] [Google Scholar]
- 27.Markland AD, Palsson O, Goode PS, Burgio KL, Busby-Whitehead J, Whitehead WE. Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. Am J Gastroenterol . 2013;108:796–803. doi: 10.1038/ajg.2013.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Roberts MC, Millikan RC, Galanko JA, Martin C, Sandler RS. Constipation, laxative use, and colon cancer in a North Carolina population. Am J Gastroenterol . 2003;98:857–864. doi: 10.1111/j.1572-0241.2003.07386.x. [DOI] [PubMed] [Google Scholar]
- 29.Chinzon D, Dias-Bastos TR, Medeiros da Silva A, Eisig JN, Latorre Mdo R. Epidemiology of constipation in São Paulo, Brazil: a population-based study. Curr Med Res Opin . 2015;31:57–64. doi: 10.1185/03007995.2014.973485. [DOI] [PubMed] [Google Scholar]
- 30.Lam , Kennedy , Chen , Lubowski , Talley Prevalence of faecal incontinence: obstetric and constipation-related risk factors; a population-based study. Colorectal Dis . 1999;1:197–203. doi: 10.1046/j.1463-1318.1999.00044.x. [DOI] [PubMed] [Google Scholar]
- 31.Shen L, Huang C, Lu X, Xu X, Jiang Z, Zhu C. Lower dietary fibre intake, but not total water consumption, is associated with constipation: a population-based analysis. J Hum Nutr Diet . 2019;32:422–431. doi: 10.1111/jhn.12589. [DOI] [PubMed] [Google Scholar]
- 32.Sandler RS, Jordan MC, Shelton BJ. Demographic and dietary determinants of constipation in the US population. Am J Public Health . 1990;80:185–189. doi: 10.2105/ajph.80.2.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Adibi P, Behzad E, Pirzadeh S, Mohseni M. Bowel habit reference values and abnormalities in young Iranian healthy adults. Dig Dis Sci . 2007;52:1810–1813. doi: 10.1007/s10620-006-9509-2. [DOI] [PubMed] [Google Scholar]
- 34.Rajput M, Saini SK. Prevalence of constipation among the general population: a community-based survey from India. Gastroenterol Nurs . 2014;37:425–429. doi: 10.1097/SGA.0000000000000074. [DOI] [PubMed] [Google Scholar]
- 35.Tokuda Y, Takahashi O, Ohde S, Shakudo M, Yanai H, Shimbo T, Fukuhara S, Hinohara S, Fukui T. Gastrointestinal symptoms in a Japanese population: a health diary study. World J Gastroenterol . 2007;13:572–578. doi: 10.3748/wjg.v13.i4.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol . 2011;106:1582–91; quiz 1581, 1592. doi: 10.1038/ajg.2011.164. [DOI] [PubMed] [Google Scholar]
- 37.Schmidt FM, Santos VL. Prevalence of constipation in the general adult population: an integrative review. J Wound Ostomy Continence Nurs . 2014;41:70–6; quiz E1. doi: 10.1097/01.WON.0000438019.21229.b7. [DOI] [PubMed] [Google Scholar]
- 38.Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol . 2004;99:750–759. doi: 10.1111/j.1572-0241.2004.04114.x. [DOI] [PubMed] [Google Scholar]
- 39.Peppas G, Alexiou VG, Mourtzoukou E, Falagas ME. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol . 2008;8:5. doi: 10.1186/1471-230X-8-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Iraji N, Keshteli AH, Sadeghpour S, Daneshpajouhnejad P, Fazel M, Adibi P. Constipation in Iran: SEPAHAN Systematic Review No. 5. Int J Prev Med . 2012;3:S34–S41. [PMC free article] [PubMed] [Google Scholar]
- 41.Chu H, Zhong L, Li H, Zhang X, Zhang J, Hou X. Epidemiology characteristics of constipation for general population, pediatric population, and elderly population in china. Gastroenterol Res Pract . 2014;2014:532734. doi: 10.1155/2014/532734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Nellesen D, Chawla A, Oh DL, Weissman T, Lavins BJ, Murray CW. Comorbidities in patients with irritable bowel syndrome with constipation or chronic idiopathic constipation: a review of the literature from the past decade. Postgrad Med . 2013;125:40–50. doi: 10.3810/pgm.2013.03.2640. [DOI] [PubMed] [Google Scholar]
- 43.Talley NJ, Lasch KL, Baum CL. A gap in our understanding: chronic constipation and its comorbid conditions. Clin Gastroenterol Hepatol . 2009;7:9–19. doi: 10.1016/j.cgh.2008.07.005. [DOI] [PubMed] [Google Scholar]
- 44.Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci . 1993;38:1569–1580. doi: 10.1007/BF01303162. [DOI] [PubMed] [Google Scholar]
- 45.Pare P, Ferrazzi S, Thompson WG, Irvine EJ, Rance L. An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol . 2001;96:3130–3137. doi: 10.1111/j.1572-0241.2001.05259.x. [DOI] [PubMed] [Google Scholar]
- 46.Chang JY, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic constipation and a possible role of analgesics. Neurogastroenterol Motil . 2007;19:905–911. doi: 10.1111/j.1365-2982.2007.00974.x. [DOI] [PubMed] [Google Scholar]
- 47.Meinds RJ, van Meegdenburg MM, Trzpis M, Broens PM. On the prevalence of constipation and fecal incontinence, and their co-occurrence, in the Netherlands. Int J Colorectal Dis . 2017;32:475–483. doi: 10.1007/s00384-016-2722-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Howell SC, Quine S, Talley NJ. Low social class is linked to upper gastrointestinal symptoms in an Australian sample of urban adults. Scand J Gastroenterol . 2006;41:657–666. doi: 10.1080/00365520500442567. [DOI] [PubMed] [Google Scholar]
- 49.Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Functional constipation and outlet delay: a population-based study. Gastroenterology . 1993;105:781–790. doi: 10.1016/0016-5085(93)90896-k. [DOI] [PubMed] [Google Scholar]
- 50.Ebling B, Gulić S, Jurcić D, Martinac M, Gmajnić R, Bilić A, Pribić S, Levak MT. Demographic, anthropometric and socioeconomic characteristics of functional constipation in Eastern Croatia. Coll Antropol . 2014;38:539–546. [PubMed] [Google Scholar]
- 51.Papatheodoridis GV, Vlachogiannakos J, Karaitianos I, Karamanolis DG. A Greek survey of community prevalence and characteristics of constipation. Eur J Gastroenterol Hepatol . 2010;22:354–360. doi: 10.1097/MEG.0b013e32832bfdf0. [DOI] [PubMed] [Google Scholar]
- 52.Moezi P, Salehi A, Molavi H, Poustchi H, Gandomkar A, Imanieh MH, Malekzadeh R. Prevalence of Chronic Constipation and Its Associated Factors in Pars Cohort Study: A Study of 9000 Adults in Southern Iran. Middle East J Dig Dis . 2018;10:75–83. doi: 10.15171/mejdd.2018.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Sorouri M, Pourhoseingholi MA, Vahedi M, Safaee A, Moghimi-Dehkordi B, Pourhoseingholi A, Habibi M, Zali MR. Functional bowel disorders in Iranian population using Rome III criteria. Saudi J Gastroenterol . 2010;16:154–160. doi: 10.4103/1319-3767.65183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Fosnes GS, Lydersen S, Farup PG. Constipation and diarrhoea - common adverse drug reactions? BMC Clin Pharmacol . 2011;11:2. doi: 10.1186/1472-6904-11-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Rey E, Balboa A, Mearin F. Chronic constipation, irritable bowel syndrome with constipation and constipation with pain/discomfort: similarities and differences. Am J Gastroenterol . 2014;109:876–884. doi: 10.1038/ajg.2014.18. [DOI] [PubMed] [Google Scholar]
- 56.Lu CL, Chang FY, Chen CY, Luo JC, Lee SD. Significance of Rome II-defined functional constipation in Taiwan and comparison with constipation-predominant irritable bowel syndrome. Aliment Pharmacol Ther . 2006;24:429–438. doi: 10.1111/j.1365-2036.2006.02949.x. [DOI] [PubMed] [Google Scholar]
- 57.Cheng C, Chan AO, Hui WM, Lam SK. Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: a population-based study. Aliment Pharmacol Ther . 2003;18:319–326. doi: 10.1046/j.1365-2036.2003.01663.x. [DOI] [PubMed] [Google Scholar]
- 58.Jun DW, Park HY, Lee OY, Lee HL, Yoon BC, Choi HS, Hahm JS, Lee MH, Lee DH, Kee CS. A population-based study on bowel habits in a Korean community: prevalence of functional constipation and self-reported constipation. Dig Dis Sci . 2006;51:1471–1477. doi: 10.1007/s10620-006-9087-3. [DOI] [PubMed] [Google Scholar]
- 59.Wald A, Mueller-Lissner S, Kamm MA, Hinkel U, Richter E, Schuijt C, Mandel KG. Survey of laxative use by adults with self-defined constipation in South America and Asia: a comparison of six countries. Aliment Pharmacol Ther . 2010;31:274–284. doi: 10.1111/j.1365-2036.2009.04169.x. [DOI] [PubMed] [Google Scholar]
- 60.Garrigues V, Gálvez C, Ortiz V, Ponce M, Nos P, Ponce J. Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. Am J Epidemiol . 2004;159:520–526. doi: 10.1093/aje/kwh072. [DOI] [PubMed] [Google Scholar]
- 61.Wald A, Scarpignato C, Mueller-Lissner S, Kamm MA, Hinkel U, Helfrich I, Schuijt C, Mandel KG. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther . 2008;28:917–930. doi: 10.1111/j.1365-2036.2008.03806.x. [DOI] [PubMed] [Google Scholar]
- 62.Harari D, Gurwitz JH, Avorn J, Bohn R, Minaker KL. Bowel habit in relation to age and gender. Findings from the National Health Interview Survey and clinical implications. Arch Intern Med . 1996;156:315–320. [PubMed] [Google Scholar]
- 63.Choung RS, Locke GR 3rd, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Alternating bowel pattern: what do people mean? Aliment Pharmacol Ther . 2006;23:1749–1755. doi: 10.1111/j.1365-2036.2006.02953.x. [DOI] [PubMed] [Google Scholar]
- 64.Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology . 1991;101:927–934. doi: 10.1016/0016-5085(91)90717-y. [DOI] [PubMed] [Google Scholar]
- 65.Choung RS, Locke GR 3rd, Rey E, Schleck CD, Baum C, Zinsmeister AR, Talley NJ. Factors associated with persistent and nonpersistent chronic constipation, over 20 years. Clin Gastroenterol Hepatol . 2012;10:494–500. doi: 10.1016/j.cgh.2011.12.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Schmidt FM, de Gouveia Santos VL, de Cássia Domansky R, Neves JM. Constipation: Prevalence and Associated Factors in Adults Living in Londrina, Southern Brazil. Gastroenterol Nurs . 2016;39:204–211. doi: 10.1097/SGA.0000000000000224. [DOI] [PubMed] [Google Scholar]
- 67.Everhart JE, Go VL, Johannes RS, Fitzsimmons SC, Roth HP, White LR. A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci . 1989;34:1153–1162. doi: 10.1007/BF01537261. [DOI] [PubMed] [Google Scholar]
- 68.Stewart WF, Liberman JN, Sandler RS, Woods MS, Stemhagen A, Chee E, Lipton RB, Farup CE. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol . 1999;94:3530–3540. doi: 10.1111/j.1572-0241.1999.01642.x. [DOI] [PubMed] [Google Scholar]
- 69.Choung RS, Rey E, Richard Locke G 3rd, Schleck CD, Baum C, Zinsmeister AR, Talley NJ. Chronic constipation and co-morbidities: A prospective population-based nested case-control study. United European Gastroenterol J . 2016;4:142–151. doi: 10.1177/2050640614558476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.van Kerkhoven LA, Eikendal T, Laheij RJ, van Oijen MG, Jansen JB. Gastrointestinal symptoms are still common in a general Western population. Neth J Med . 2008;66:18–22. [PubMed] [Google Scholar]
- 71.Haug TT, Mykletun A, Dahl AA. Are anxiety and depression related to gastrointestinal symptoms in the general population? Scand J Gastroenterol . 2002;37:294–298. doi: 10.1080/003655202317284192. [DOI] [PubMed] [Google Scholar]
- 72.Gaburri M, Bassotti G, Bacci G, Cinti A, Bosso R, Ceccarelli P, Paolocci N, Pelli MA, Morelli A. Functional gut disorders and health care seeking behavior in an Italian non-patient population. Recenti Prog Med . 1989;80:241–244. [PubMed] [Google Scholar]
- 73.Heaton KW, Cripps HA. Straining at stool and laxative taking in an English population. Dig Dis Sci . 1993;38:1004–1008. doi: 10.1007/BF01295713. [DOI] [PubMed] [Google Scholar]
- 74.Esteban y Peña M, García RJ, Olalla JM, Llanos EV, de Miguel AG, Cordero XF. Impact of the most frequent chronic health conditions on the quality of life among people aged > 15 years in Madrid. Eur J Public Health . 2010;20:78–84. doi: 10.1093/eurpub/ckp098. [DOI] [PubMed] [Google Scholar]
- 75.Enck P, Leinert J, Smid M, Köhler T, Schwille-Kiuntke J. Prevalence of constipation in the German population - a representative survey (GECCO) United European Gastroenterol J . 2016;4:429–437. doi: 10.1177/2050640615603009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol . 1998;93:1816–1822. doi: 10.1111/j.1572-0241.1998.00526.x. [DOI] [PubMed] [Google Scholar]
- 77.Chen LY, Ho KY, Phua KH. Normal bowel habits and prevalence of functional bowel disorders in Singaporean adults--findings from a community based study in Bishan. Community Medicine GI Study Group. Singapore Med J . 2000;41:255–258. [PubMed] [Google Scholar]
- 78.Chang FY, Chen PH, Wu TC, Pan WH, Chang HY, Wu SJ, Yeh NH, Tang RB, Wu L, James FE. Prevalence of functional gastrointestinal disorders in Taiwan: questionnaire-based survey for adults based on the Rome III criteria. Asia Pac J Clin Nutr . 2012;21:594–600. [PubMed] [Google Scholar]
- 79.Jeong JJ, Choi MG, Cho YS, Lee SG, Oh JH, Park JM, Cho YK, Lee IS, Kim SW, Han SW, Choi KY, Chung IS. Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol . 2008;14:6388–6394. doi: 10.3748/wjg.14.6388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Talley NJ, Boyce P, Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut . 1998;42:690–695. doi: 10.1136/gut.42.5.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Koloski NA, Jones M, Young M, Talley NJ. Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther . 2015;41:856–866. doi: 10.1111/apt.13149. [DOI] [PubMed] [Google Scholar]
- 82.Bytzer P, Howell S, Leemon M, Young LJ, Jones MP, Talley NJ. Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut . 2001;49:66–72. doi: 10.1136/gut.49.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Cumulative incidence of chronic constipation: a population-based study 1988-2003. Aliment Pharmacol Ther . 2007;26:1521–1528. doi: 10.1111/j.1365-2036.2007.03540.x. [DOI] [PubMed] [Google Scholar]
- 84.Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol . 2002;97:2290–2299. doi: 10.1111/j.1572-0241.2002.05783.x. [DOI] [PubMed] [Google Scholar]
- 85.Pourhoseingholi MA, Kaboli SA, Pourhoseingholi A, Moghimi-Dehkordi B, Safaee A, Mansoori BK, Habibi M, Zali MR. Obesity and functional constipation; a community-based study in Iran. J Gastrointestin Liver Dis . 2009;18:151–155. [PubMed] [Google Scholar]
- 86.Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med . 2001;161:1989–1996. doi: 10.1001/archinte.161.16.1989. [DOI] [PubMed] [Google Scholar]
- 87.Branch RL, Butt TF. Drug-induced constipation. Adv Drug React Bull . 2009;257:987–990. [Google Scholar]
- 88.Toney RC, Wallace D, Sekhon S, Agrawal RM. Medication induced constipation and diarrhea. Pract Gastroenterol . 2008;32:12–28. [Google Scholar]
- 89.Harkness GA. Epidemiology in Nursing Practice. St. Louis: Mosby-Year Book Inc., 1995: 78-83. [Google Scholar]
- 90.Hemkens LG, Ewald H, Naudet F, Ladanie A, Shaw JG, Sajeev G, Ioannidis JPA. Interpretation of epidemiologic studies very often lacked adequate consideration of confounding. J Clin Epidemiol . 2018;93:94–102. doi: 10.1016/j.jclinepi.2017.09.013. [DOI] [PubMed] [Google Scholar]
- 91.Gallagher P, O'Mahony D. Constipation in old age. Best Pract Res Clin Gastroenterol . 2009;23:875–887. doi: 10.1016/j.bpg.2009.09.001. [DOI] [PubMed] [Google Scholar]
- 92.Tack J, Müller-Lissner S, Stanghellini V, Boeckxstaens G, Kamm MA, Simren M, Galmiche JP, Fried M. Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil . 2011;23:697–710. doi: 10.1111/j.1365-2982.2011.01709.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Pare P. The approach to diagnosis and treatment of chronic constipation: suggestions for a general practitioner. Can J Gastroenterol . 2011;25 Suppl B:36B–40B. doi: 10.1155/2011/368189. [DOI] [PMC free article] [PubMed] [Google Scholar]